2025
SJR Q1
JCR Q1 · 4,7
9 eşleşen makale
SCIE
Dergi ayrıntısı
Expert Opinion on Therapeutic Patents
- Yayıncı
- Taylor and Francis Ltd.
- Ülke
- United Kingdom · Western Europe
- Tür
- journal
- ISSN
-
1354377617447674
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 1,098
- Quartile Q1
- H-Index 98
- Atıf/yayın 4,92
- Doküman (3y) 185
- Atıf (3y) 929
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 4,7
- 5Y JIF 4,9
- JCI 0,66
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Drug Discovery Q1
- Medicine (miscellaneous) Q1
- Pharmacology Q1
Alanlar
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS kategorileri
- Chemistry, Medicinal | Pharmacology & Pharmacy
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,098 | 4,7 | 4,9 | 0,66 | Q2 | 98 |
| 2024 | Q1 | Q1 | 1,2 | 4,6 | 5,3 | 0,79 | Q2 | 93 |
| 2023 | Q1 | Q1 | 1,291 | 5,4 | 6,4 | 0,85 | Q2 | 93 |
| 2022 | Q1 | Q1 | 1,292 | 6,6 | 5,9 | 0,84 | Q2 | 93 |
| 2021 | Q1 | Q1 | 1,065 | 6,7 | 5,9 | 1,04 | Q1 | 93 |
| 2020 | Q1 | Q1 | 1,121 | 6,7 | 4,9 | 1,14 | Q1 | 93 |
| 2019 | Q1 | Q1 | 1,027 | 5,6 | 4 | 1,02 | Q1 | 93 |
| 2018 | — | Q1 | — | 3,7 | 3,7 | 0,76 | Q2 | — |
| 2017 | Q1 | Q2 | 0,926 | 2,9 | 3,4 | 0,62 | Q3 | 93 |
| 2016 | Q1 | Q2 | 1,057 | 3 | 3,5 | — | — | 93 |
| 2015 | Q1 | Q1 | 1,081 | 4,6 | 3,6 | — | — | 93 |
| 2014 | Q1 | Q1 | 1,31 | 4,3 | 3,3 | — | — | 93 |
| 2013 | Q1 | Q1 | 1,188 | 3,4 | 2,9 | — | — | 93 |
| 2012 | Q1 | Q1 | 1,33 | 3,5 | 2,5 | — | — | 93 |
| 2011 | Q1 | Q1 | 1,129 | 3,6 | 2,1 | — | — | 93 |
| 2010 | Q2 | Q1 | 0,687 | 2,4 | 1,6 | — | — | 93 |
| 2009 | — | Q3 | — | 1,3 | 1,3 | — | — | — |
| 2008 | — | Q3 | — | 1,3 | 1,2 | — | — | — |
| 2007 | — | Q2 | — | 1,6 | 1,4 | — | — | — |
| 2006 | — | Q2 | — | 1,5 | — | — | — | — |
| 2005 | — | Q2 | — | 1,4 | — | — | — | — |
| 2004 | — | Q2 | — | 1,5 | — | — | — | — |
| 2003 | — | Q1 | — | 1,6 | — | — | — | — |
| 2002 | — | Q2 | — | 1,4 | — | — | — | — |
| 2001 | — | Q2 | — | 1,1 | — | — | — | — |
| 2000 | — | Q1 | — | 1,2 | — | — | — | — |
| 1999 | — | Q3 | — | 1,2 | — | — | — | — |
| 1998 | — | Q3 | — | 0,8 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q3 | 21/72 |
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q2 | 78/356 |
| 2024 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q2 | 20/72 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q2 | 57/352 |
| 2023 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q2 | 12/72 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q2 | 32/354 |
| 2022 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q2 | 9/60 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q2 | 30/278 |
| 2021 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q2 | 6/63 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 37/279 |
| 2020 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q2 | 4/62 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 21/276 |
| 2019 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q2 | 4/61 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 20/271 |
| 2018 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q2 | 18/61 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q2 | 64/267 |
| 2017 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q3 | 25/59 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q3 | 102/261 |
| 2016 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 20/60 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 85/257 |
| 2015 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 4/59 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 31/255 |
| 2014 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 5/59 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 33/255 |
| 2013 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 12/58 |
| 2013 | MEDICINE, LEGAL | SCIE | Q1 | — | 1/16 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 57/256 |
| 2012 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 12/59 |
| 2012 | MEDICINE, LEGAL | SCIE | Q1 | — | 2/16 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 56/261 |
| 2011 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 10/59 |
| 2011 | MEDICINE, LEGAL | SCIE | Q1 | — | 1/15 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 54/261 |
| 2010 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 22/54 |
| 2010 | MEDICINE, LEGAL | SCIE | Q1 | — | 3/13 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 118/252 |
| 2009 | MEDICINE, LEGAL | SCIE | Q3 | — | 7/11 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 179/237 |
| 2008 | MEDICINE, LEGAL | SCIE | Q3 | — | 6/10 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 161/219 |
| 2007 | MEDICINE, LEGAL | SCIE | Q2 | — | 4/9 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 134/205 |
| 2006 | MEDICINE, LEGAL | SCIE | Q2 | — | 3/9 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 128/199 |
| 2005 | MEDICINE, LEGAL | SCIE | Q2 | — | 4/9 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 128/193 |
| 2004 | MEDICINE, LEGAL | SCIE | Q2 | — | 3/9 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 112/187 |
| 2003 | MEDICINE, LEGAL | SCIE | Q1 | — | 2/9 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 95/185 |
| 2002 | MEDICINE, LEGAL | SCIE | Q2 | — | 3/9 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 104/188 |
| 2001 | MEDICINE, LEGAL | SCIE | Q2 | — | 3/8 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 119/186 |
| 2000 | MEDICINE, LEGAL | SCIE | Q1 | — | 2/9 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 102/181 |
| 1999 | MEDICINE, LEGAL | SCIE | Q3 | — | 6/10 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 88/175 |
| 1998 | MEDICINE, LEGAL | SCIE | Q3 | — | 5/9 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 111/178 |